Document Detail


The effect of renal function on serum levels of CA 125.
MedLine Citation:
PMID:  7672704     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Serum assays for CA 125 are used to monitor disease status in patients undergoing treatment for epithelial ovarian cancer. While a number of benign gynecologic as well as benign and malignant nongynecologic conditions are associated with CA 125 elevations, the established "normal" range describes a healthy population of women. The metabolism and clearance of CA 125 is not well understood. Because mild degrees of renal impairment frequently occur in ovarian cancer patients, we investigated the effect of impaired renal function on basal CA 125 in a population of female dialysis patients. METHODS: Twenty-five women on hemodialysis were selected at random. Patients ranged in age from 29 to 87 years. Renal disease was secondary in most cases to diabetes mellitus or hypertension. The creatinine clearance was less than 10 cc/min for all patients. The duration of dialysis ranged from 3 months to 14 years. Serum levels of CA 125 were measured using monoclonal antibodies in an immunoradiometric assay. RESULTS: The mean of duplicate determinations for 23 of 25 (92%) patients fell within the normal range for otherwise healthy women (< 35 U/ml). There was no apparent correlation between CA 125 level and age, menopausal status, BUN, serum creatinine, adequacy of dialysis, or primary underlying diagnosis. Of the 2 patients (8%) with CA 125 levels above the normal range, 1 was premenopausal and the other was postmenopausal; their CA 125 elevations were marginal (49.81 and 50.51). CONCLUSIONS: The results of this study demonstrate that even marked renal insufficiency is not itself associated with significant elevations of CA 125 above the normal range selected for otherwise healthy women. The development of renal insufficiency during treatment for ovarian cancer should not alter the interpretation of serum levels of CA 125.
Authors:
A W Menzin; S Kobrin; E Pollak; D B Goodman; S C Rubin
Related Documents :
128534 - Biosynthesis and metabolism of androgenic hormones in cancer of the prostate.
12735914 - Serum creatine kinase is elevated in patients with parkinson's disease: a case controll...
10561764 - The outcome of trial off catheter after acute retention of urine.
21183884 - Significance of in situ hybridization results for ebv-encoded rna in post-transplantati...
8549434 - Distribution of event-related potentials in patients with dementia.
8764524 - Myocardial infarction in sickle cell disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Gynecologic oncology     Volume:  58     ISSN:  0090-8258     ISO Abbreviation:  Gynecol. Oncol.     Publication Date:  1995 Sep 
Date Detail:
Created Date:  1995-10-17     Completed Date:  1995-10-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0365304     Medline TA:  Gynecol Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  375-7     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Pennsylvania Medical Center, Philadelphia 19104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
CA-125 Antigen / blood*
Creatinine / blood
Female
Humans
Immunoradiometric Assay
Kidney / physiopathology*
Kidney Failure, Chronic / physiopathology*,  therapy
Middle Aged
Renal Dialysis
Chemical
Reg. No./Substance:
0/CA-125 Antigen; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Absence of significant germ line p53 mutations in ovarian cancer patients.
Next Document:  High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestati...